Buscar

01/10/2024 Clinical value of plasma pTau181 to predict Alzheimer's ' s disease pathology in a large real-world cohort of a memory clinic
Cano, A, Capdevila, M, Puerta, R, Arranz, J, Montrreal, L, de Rojas, I, García-González, P, Olivé, C, García-Gutiérrez, F, Sotolongo-Grau, O, Orellana, A, Aguilera, N, Ramis, M, Rosende-Roca, M, Lleó, A, Fortea, J, Tartari, JP, Lafuente, A, Vargas, L, Pérez-Cordón, A, Muñoz, N, Sanabria, A, Alegret, M, Morató, X, Tárraga, L, Fernández, V, Marquié, M, Valero, S, Alcolea, D, Boada, M, Ruiz, A. Clinical value of plasma pTau181 to predict Alzheimer's ' s disease pathology in a large real-world cohort of a memory clinic. EBioMedicine. 2024; 108DOI:10.1016/j.ebiom.2024.105345. PMID:39299003. IF:10.800(Q1/1D).
01/10/2024 Insights into the use of biomarkers in clinical trials in Alzheimer's ' s disease
Pascoal, TA, Aguzzoli, CS, Lussier, FZ, Crivelli, L, Suemoto, CK, Fortea, J, Rosa-Neto, P, Zimmer, ER, Ferreira, PCL, Bellaver, B. Insights into the use of biomarkers in clinical trials in Alzheimer's ' s disease. EBioMedicine. 2024; 108DOI:10.1016/j.ebiom.2024.105322. PMID:39366844. IF:10.800(Q1/1D).
01/10/2024 Clinical and research application of fluid bio markers in autosomal dominant Alzheimer's disease and Down syndrome
Carmona-Iragui, M, 'Connor, AO, Llibre-Guerra, J, Lao, PT, Ashton, NJ, Fortea, J, Sánchez-Valle, R. Clinical and research application of fluid bio markers in autosomal dominant Alzheimer's disease and Down syndrome. EBioMedicine. 2024; 108DOI:10.1016/j.ebiom.2024.105327. PMID:39366843. IF:10.800(Q1/1D).
01/10/2024 Challenges in the practical implementation of blood biomarkers for Alzheimer's disease
Schöll, M, Verberk, IMW, del Campo, M, Delaby, C, Therriault, J, Chong, JR, Palmqvist, S, Alcolea, D. Challenges in the practical implementation of blood biomarkers for Alzheimer's disease. Lancet Healthy Longevity. 2024; 5(10)DOI:10.1016/j.lanhl.2024.07.013. PMID:39369727. IF:14.600(Q1/1D).
12/09/2024 Structural connectivity modifications following deep brain stimulation of the subcallosal cingulate and nucleus accumbens in severe anorexia nervosa
Abellaneda-Pérez, K, Delgado-Martínez, I, Salgado, P, Ginés, JM, Guardiola, R, Vaqué-Alcázar, L, Roca-Ventura, A, Molist-Puigdomènech, R, Manero, RM, Viles-Garcia, M, Medrano-Martorell, S, Bartrés-Faz, D, Pascual-Leone, A, Pérez-Solà, V, Villalba-Martínez, G. Structural connectivity modifications following deep brain stimulation of the subcallosal cingulate and nucleus accumbens in severe anorexia nervosa. ACTA NEUROCHIRURGICA. 2024; 166(1)DOI:10.1007/s00701-024-06258-w. PMID:39261306. IF:1.900(Q2/4D).
10/09/2024 The SORL1 p.Y1816C variant causes impaired endosomal dimerization and autosomal dominant Alzheimer's disease
Jensen, AMG, Raska, J, Fojtik, P, Monti, G, Lunding, M, Bartova, S, Pospisilova, V, van der Lee, SJ, Van Dongen, J, Bossaerts, L, Van Broeckhoven, C, Dols-Icardo, O, Lléo, A, Bellini, S, Ghidoni, R, Hulsman, M, Petsko, GA, Sleegers, K, Bohaciakova, D, Holstege, H, Andersen, OM. The SORL1 p.Y1816C variant causes impaired endosomal dimerization and autosomal dominant Alzheimer's disease. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2024; 121(37)DOI:10.1073/pnas.2408262121. PMID:39226352. IF:9.100(Q1/2D).
01/09/2024 Risk factors and clinical impact of multidrug resistance in healthcare-associated bacteraemic urinary tract infections: a post-hoc analysis of a multicentre prospective cohort in Spain
Gómez-Zorrilla, S, Becerra-Aparicio, F, Sendra, E, Zamorano, L, Grau, I, Pintado, V, Padilla, B, Benito, N, Boix-Palop, L, Fariñas, MC, Peñaranda, M, Gamallo, MR, Martinez, JA, Morte-Romea, E, Del Pozo, JL, Montesinos, IL, Durán-Jordà, X, Ponz, R, Cotarelo, M, Cantón, R, Oliver, A, Ruiz-Garbajosa, P, Horcajada, JP. Risk factors and clinical impact of multidrug resistance in healthcare-associated bacteraemic urinary tract infections: a post-hoc analysis of a multicentre prospective cohort in Spain. JOURNAL OF HOSPITAL INFECTION. 2024; 151DOI:10.1016/j.jhin.2024.05.020. PMID:38945399. IF:3.100(Q1/3D).
30/08/2024 Migraine treatment consensus document of the Spanish Society of Neurology (SEN), Spanish Society of Family and Community Medicine (SEMFYC), Society of Primary Care Medicine (SEMERGEN) and Spanish Association of Migraine and Headache (AEMICE) on migraine treatment
Belvís, R, Irimia, P, González, N, García-Ull, J, Pozo-Rosich, P, López-Bravo, A, Morollón, N, Quintas, S, Plana, A, Baz, PG, Tentor, A, Artiles, NG, León, FJ, Martín, MP, Rivera, I, Ramírez, R, Colomina, I, Lainez, JM, Pascual, J. Migraine treatment consensus document of the Spanish Society of Neurology (SEN), Spanish Society of Family and Community Medicine (SEMFYC), Society of Primary Care Medicine (SEMERGEN) and Spanish Association of Migraine and Headache (AEMICE) on migraine treatment. MEDICINA CLINICA. 2024; 163(4)DOI:10.1016/j.medcli.2024.02.006. PMID:38643025. IF:2.100(Q2/3D).
13/08/2024 Impact of repetitive negative thinking on subjective cognitive decline: insights into cognition and brain structure
Mulet-Pons, L, Solé-Padullés, C, Cabello-Toscano, M, Abellaneda-Pérez, K, Perellón-Alfonso, R, Cattaneo, G, Sánchez, JS, Alviarez-Schulze, V, Bargalló, N, Tormos-Muñoz, JM, Pascual-Leone, A, Bartrés-Faz, D, Vaqué-Alcázar, L. Impact of repetitive negative thinking on subjective cognitive decline: insights into cognition and brain structure. Frontiers in Aging Neuroscience. 2024; 16DOI:10.3389/fnagi.2024.1441359. PMID:39193493. IF:4.500(Q1/2D).
01/08/2024 MADRE MIA: Monoclonal Antibody Duration of REsponse in MIgraine After treatment interruption: A prospective multicentric study on 2164 patients
Iñiguez, AE, Peral, ALG, de Teherán, JD, Lasaosa, SS, Godia, EC, Bujanda, MM, Pérez, NR, Juanes, FV, Soblechero, AS, Díez, FI, Fernández, MTT, Baurier, VO, García-Moncó, JC, Arilla, SA, Sánchez, AJ, Mínguez-Olaondo, A, Nieva, AR, Porta-Etessam, J, Zubizarreta, IK, López-Bravo, A, Villanueva, MH, Gago-Viega, A, Oria, CG, López, AA, Sánchez-Mateos, NM, Castrillo, AS, Treviño, C, Sierra-Mencía, A, García, AR, López, JAM, Pérez, MPN, Zorrilla-Lequerica, PM, Escudero, MDA, Ros, AL, Luque, SG, Alvarez, M, Fabra, NF, Colina, NR, Rodriguez-Vico, JS, Salgado, MR, García, NG, Urabayen, AE, Vendrell, AM, Lázaro, IF, del Rincón, CR, Pérez, RL, Layos-Romero, A, Nieto, RB, Osorio, YG, Guisado-Alonso, D, Durán, AO, López, JT, González-Fernández, L, Fernández-Fernández, S, Rodriguez, HM, García, AG, Díaz, SC, Gutierrez, SQ, Rodriguez, NS, Sánchez, MTS, Galindo, TM, Peña, SF, dela Cadiniere, MDLI, Martínez, AG, Azorín, DG. MADRE MIA: Monoclonal Antibody Duration of REsponse in MIgraine After treatment interruption: A prospective multicentric study on 2164 patients. JOURNAL OF HEADACHE AND PAIN. 2024; 25DOI:. PMID:. IF:7.900(Q1/1D).
01/08/2024 The comparative safety and efficacy of anti-migraine medications and devices in migraine prophylaxis: a network meta-analysis
Nieto, RB, Láinez, MJ, Huth, M, Francis, P, Singh, S, McMaster, A, Hasham, SN, Suthar, B, Srivastava, PK. The comparative safety and efficacy of anti-migraine medications and devices in migraine prophylaxis: a network meta-analysis. JOURNAL OF HEADACHE AND PAIN. 2024; 25DOI:. PMID:. IF:7.900(Q1/1D).
01/08/2024 RE-START STUDY: Multicenter study to assess response after reintroduction of anti-CGRP antibodies in patients with migraine
Martínez, AG, del Rincón, CR, Gutierrez, SQ, Azorín, DG, Lázaro, IF, Peral, ALG, Osorio, YG, Díez, FI, Iñiguez, AE, Luque, SG, Villanueva, MH, Díaz, SC, Vendrell, AM, Juanes, FV, Ros, AL, Soblechero, AS, Sánchez-Mateos, NM, Belvis, R, Zubizarreta, IK, Urabayen, AE, Rodrígue-Vico, JS, Sanchez, AJ, García, AG, Pérez, MPN, Montes, N, Gago-Viega, A. RE-START STUDY: Multicenter study to assess response after reintroduction of anti-CGRP antibodies in patients with migraine. JOURNAL OF HEADACHE AND PAIN. 2024; 25DOI:. PMID:. IF:7.900(Q1/1D).
11/07/2024 Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia
Manzoni, C, Kia, DA, Ferrari, R, Leonenko, G, Costa, B, Saba, V, Jabbari, E, Tan, MMX, Albani, D, Alvarez, V, Alvarez, I, Andreassen, OA, Angiolillo, A, Arighi, A, Baker, M, Benussi, L, Bessi, V, Binetti, G, Blackburn, DJ, Boada, M, Boeve, BF, Borrego-Ecija, S, Borroni, B, Bråthen, G, Brooks, WS, Bruni, AC, Caroppo, P, Bandres-Ciga, S, Clarimon, J, Colao, R, Cruchaga, C, Danek, A, de Boer, SCM, de Rojas, I, di Costanzo, A, Dickson, DW, Diehl-Schmid, J, Dobson-Stone, C, Dols-Icardo, O, Donizetti, A, Dopper, E, Durante, E, Ferrari, C, Forloni, G, Frangipane, F, Fratiglioni, L, Kramberger, MG, Galimberti, D, Gallucci, M, García-González, P, Ghidoni, R, Giaccone, G, Graff, C, Graff-Radford, NR, Grafman, J, Halliday, GM, Hernandez, DG, Hjermind, LE, Hodges, JR, Holloway, G, Huey, ED, Illán-Gala, I, Josephs, KA, Knopman, DS, Kristiansen, M, Kwok, JB, Leber, I, Leonard, HL, Libri, I, Lleo, A, Mackenzie, IR, Madhan, GK, Maletta, R, Marquié, M, Maver, A, Menendez-Gonzalez, M, Milan, G, Miller, BL, Morris, CM, Morris, HR, Nacmias, B, Newton, J, Nielsen, JE, Nilsson, C, Novelli, V, Padovani, A, Pal, S, Pasquier, F, Pastor, P, Perneczky, R, Peterlin, B, Petersen, RC, Piguet, O, Pijnenburg, YAL, Puca, AA, Rademakers, R, Rainero, I, Reus, LM, Richardson, AMT, Riemenschneider, M, Rogaeva, E, Rogelj, B, Rollinson, S, Rosen, H, Rossi, G, Rowe, JB, Rubino, E, Ruiz, A, Salvi, E, Sanchez-Valle, R, Sando, SB, Santillo, AF, Saxon, JA, Schlachetzki, JCM, Scholz, SW, Seelaar, H, Seeley, WW, Serpente, M, Sorbi, S, Sordon, S, St George-Hyslop, P, Thompson, JC, Van Broeckhoven, C, Van Deerlin, VM, Van der Lee, SJ, Van Swieten, J, Tagliavini, F, van der Zee, J, Veronesi, A, Vitale, E, Waldo, ML, Yokoyama, JS, Nalls, MA, Momeni, P, Singleton, AB, Hardy, J, Escott-Price, V. Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia. AMERICAN JOURNAL OF HUMAN GENETICS. 2024; 111(7)DOI:10.1016/j.ajhg.2024.05.017. PMID:38889728. IF:8.100(Q1/1D).
03/07/2024 Genome sequence analyses identify novel risk loci for multiple system atrophy
Chia, R, Ray, A, Shah, Z, Ding, J, Ruffo, P, Fujita, M, Menon, V, Saez-Atienzar, S, Reho, P, Kaivola, K, Walton, RL, Reynolds, RH, Karra, R, Sait, S, Akcimen, F, Diez-Fairen, M, Alvarez, I, Fanciulli, A, Stefanova, N, Seppi, K, Duerr, S, Leys, F, Krismer, F, Sidoroff, V, Zimprich, A, Pirker, W, Rascol, O, Foubert-Samier, A, Meissner, WG, Tison, F, Pavy-Le Traon, A, Pellecchia, MT, Barone, P, Russillo, MC, Marín-Lahoz, J, Kulisevsky, J, Torres, S, Mir, P, Periñán, MT, Proukakis, C, Chelban, V, Wu, L, Goh, YY, Parkkinen, L, Hu, MT, Kobylecki, C, Saxon, JA, Rollinson, S, Garland, E, Biaggioni, I, Litvan, I, Rubio, I, Alcalay, RN, Kwei, KT, Lubbe, SJ, Mao, QW, Flanagan, ME, Castellani, RJ, Khurana, V, Ndayisaba, A, Calvo, A, Mora, G, Canosa, A, Floris, G, Bohannan, RC, Moore, A, Norcliffe-Kaufmann, L, Palma, JA, Kaufmann, H, Kim, C, Iba, M, Masliah, E, Dawson, TM, Rosenthal, LS, Pantelyat, A, Albert, MS, Pletnikova, O, Troncoso, JC, Infante, J, Lage, C, Sánchez-Juan, P, Serrano, GE, Beach, TG, Pastor, P, Morris, HR, Albani, D, Clarimon, J, Wenning, GK, Hardy, JA, Ryten, M, Topol, E, Torkamani, A, Chio, A, Bennett, DA, De Jager, PL, Low, PA, Singer, W, Cheshire, WP, Wszolek, ZK, Dickson, DW, Traynor, BJ, Gibbs, JR, Dalgard, CL, Ross, OA, Houlden, H, Scholz, SW. Genome sequence analyses identify novel risk loci for multiple system atrophy. NEURON. 2024; 112(13)DOI:10.1016/j.neuron.2024.04.002. PMID:38701790. IF:15.000(Q1/1D).
01/06/2024 Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS
Chatterjee, M, Özdemir, S, Fritz, C, Möbius, W, Kleineidam, L, Mandelkow, E, Biernat, J, Dogdu, C, Peters, O, Cosma, NC, Wang, X, Schneider, LS, Priller, J, Spruth, E, Kühn, AA, Krause, P, Klockgether, T, Vogt, IR, Kimmich, O, Spottke, A, Hoffmann, DC, Fliessbach, K, Miklitz, C, McCormick, C, Weydt, P, Falkenburger, B, Brandt, M, Guenther, R, Dinter, E, Wiltfang, J, Hansen, N, Bähr, M, Zerr, I, Flöel, A, Nestor, PJ, Düzel, E, Glanz, W, Incesoy, E, Bürger, K, Janowitz, D, Perneczky, R, Rauchmann, BS, Hopfner, F, Wagemann, O, Levin, J, Teipel, S, Kilimann, I, Goerss, D, Prudlo, J, Gasser, T, Brockmann, K, Mengel, D, Zimmermann, M, Synofzik, M, Wilke, C, Selma-Gonzáalez, J, Turon-Sans, J, Santos-Santos, MA, Alcolea, D, Rubio-Guerra, S, Fortea, J, Carbayo, A, Lleó, A, Rojas-García, R, Illán-Gala, I, Wagner, M, Frommann, I, Roeske, S, Bertram, L, Heneka, MT, Brosseron, F, Ramirez, A, Schmid, M, Beschorner, R, Halle, A, Herms, J, Neumann, M, Barthélemy, NR, Bateman, RJ, Rizzu, P, Heutink, P, Dols-Icardo, O, Höglinger, G, Hermann, A, Schneider, A. Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS. NATURE MEDICINE. 2024; 30(6)DOI:10.1038/s41591-024-02937-4. PMID:38890531. IF:50.000(Q1/1D).
01/06/2024 Carvedilol versus propranolol in the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis
Fortea, J, Alvarado-Tapias, E, Simbrunner, B, Ezcurra, I, Hernández-Gea, V, Aracil, CF, Herrera, EL, Puente, A, Roig, C, Reiberger, T, García-Pagán, JC, Panero, JLC, Mandorfer, M, Villanueva, C, Crespo, J. Carvedilol versus propranolol in the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis. JOURNAL OF HEPATOLOGY. 2024; 80DOI:. PMID:. IF:33.000(Q1/1D).
01/06/2024 Association between cerebrospinal fluid fatty acid profile, neuroimaging markers of hypothalamic inflammation, and weight loss after bariatric surgery
Pané, A, Videla, L, Calvet, A, Castro-Barquero, S, Viaplana, J, Ibarzabal, A, Ortega, E, Fortea, J, Jiménez, A, Chiva-Blanch, G. Association between cerebrospinal fluid fatty acid profile, neuroimaging markers of hypothalamic inflammation, and weight loss after bariatric surgery. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).
01/12/2025 Novel predictors of Alzheimer's disease in Down syndrome identified using machine learning
Rubenstein, E, Tewolde, S, Michals, A, Fortea, J, Jimenez, MP, Skotko, BG, Tripodis, Y, Weuve, J, Rosellini, AJ. Novel predictors of Alzheimer's disease in Down syndrome identified using machine learning. JOURNAL OF ALZHEIMERS DISEASE. 2025; 108(3)DOI:10.1177/13872877251385423. PMID:41105592. IF:3.100(Q2/5D).
01/12/2025 Cortical microstructure is associated with disease severity and clinical progression in genetic frontotemporal dementia: a GENFI study
Rodriguez-Vieitez, E, Rydell, MT, Ullgren, A, Montal, V, Illán-Gala, I, Fortea, J, Jelic, V, Bouzigues, A, Russell, LL, Foster, PH, Ferry-Bolder, E, van Swieten, JC, Jiskoot, LC, Seelaar, H, Sanchez-Valle, R, Laforce, R, Galimberti, D, Vandenberghe, R, de Mendonça, A, Tiraboschi, P, Santana, I, Gerhard, A, Levin, J, Sorbi, S, Otto, M, Pasquier, F, Ducharme, S, Butler, CR, Le Ber, I, Finger, E, Tartaglia, MC, Masellis, M, Rowe, JB, Synofzik, M, Moreno, F, Borroni, B, Rohrer, JD, Westman, E, Graff, C, Genetic Frontotemporal Dementia Initiative GENFI. Cortical microstructure is associated with disease severity and clinical progression in genetic frontotemporal dementia: a GENFI study. MOLECULAR PSYCHIATRY. 2025; 30(12)DOI:10.1038/s41380-025-03280-x. PMID:41068257. IF:10.100(Q1/1D).
21/11/2025 Hepcidin as an emerging predictor biomarker of leptomeningeal metastases in patients with metastatic breast cancer
Delaby, C, Al Herk, A, Hirtz, C, Jacot, W, Laigre, M, Pouderoux, S, Pradeilles, N, Lehmann, S, Darlix, A. Hepcidin as an emerging predictor biomarker of leptomeningeal metastases in patients with metastatic breast cancer. BMC CANCER. 2025; 25(1)DOI:10.1186/s12885-025-15124-6. PMID:41272605. IF:3.400(Q2/4D).